These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

557 related articles for article (PubMed ID: 30167431)

  • 21. Myeloperoxidase-Antineutrophil Cytoplasmic Antibody (ANCA)-Positive Granulomatosis With Polyangiitis (Wegener's) Is a Clinically Distinct Subset of ANCA-Associated Vasculitis: A Retrospective Analysis of 315 Patients From a German Vasculitis Referral Center.
    Schirmer JH; Wright MN; Herrmann K; Laudien M; Nölle B; Reinhold-Keller E; Bremer JP; Moosig F; Holle JU
    Arthritis Rheumatol; 2016 Dec; 68(12):2953-2963. PubMed ID: 27333332
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Myeloperoxidase-Antineutrophil Cytoplasmic Antibody (ANCA)-Positive and ANCA-Negative Patients With Granulomatosis With Polyangiitis (Wegener's): Distinct Patient Subsets.
    Miloslavsky EM; Lu N; Unizony S; Choi HK; Merkel PA; Seo P; Spiera R; Langford CA; Hoffman GS; Kallenberg CG; St Clair EW; Tchao NK; Fervenza F; Monach PA; Specks U; Stone JH
    Arthritis Rheumatol; 2016 Dec; 68(12):2945-2952. PubMed ID: 27428559
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical outcomes of treatment of anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis based on ANCA type.
    Unizony S; Villarreal M; Miloslavsky EM; Lu N; Merkel PA; Spiera R; Seo P; Langford CA; Hoffman GS; Kallenberg CM; St Clair EW; Ikle D; Tchao NK; Ding L; Brunetta P; Choi HK; Monach PA; Fervenza F; Stone JH; Specks U;
    Ann Rheum Dis; 2016 Jun; 75(6):1166-9. PubMed ID: 26621483
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Relevance of Combined Clinicopathologic Phenotype and Antineutrophil Cytoplasmic Autoantibody Serotype in the Diagnosis of Antineutrophil Cytoplasmic Autoantibody Vasculitis.
    Alba MA; Jennette JC; Hu Y; Poulton CJ; Blazek L; Derebail VK; Falk RJ; Hogan SL
    Kidney Int Rep; 2022 Dec; 7(12):2676-2690. PubMed ID: 36506241
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Brief Report: Circulating Cytokine Profiles and Antineutrophil Cytoplasmic Antibody Specificity in Patients With Antineutrophil Cytoplasmic Antibody-Associated Vasculitis.
    Berti A; Warner R; Johnson K; Cornec D; Schroeder D; Kabat B; Langford CA; Hoffman GS; Fervenza FC; Kallenberg CGM; Seo P; Spiera R; St Clair EW; Brunetta P; Stone JH; Merkel PA; Specks U; Monach PA;
    Arthritis Rheumatol; 2018 Jul; 70(7):1114-1121. PubMed ID: 29693324
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Prevalence and Management of Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis in China.
    Li ZY; Ma TT; Chen M; Zhao MH
    Kidney Dis (Basel); 2016 Mar; 1(4):216-23. PubMed ID: 27536681
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hallmark trials in ANCA-associated vasculitis (AAV) for the pediatric rheumatologist.
    Lee JJY; Alsaleem A; Chiang GPK; Limenis E; Sontichai W; Yeung RSM; Akikusa J; Laxer RM
    Pediatr Rheumatol Online J; 2019 Jun; 17(1):31. PubMed ID: 31242923
    [TBL] [Abstract][Full Text] [Related]  

  • 28. ANCA-Associated Vasculitis in a Patient Presenting With Rapid Progressive Glomerulonephritis.
    Singh A; Everest S; Nguyen L; Kasari M
    Cureus; 2021 Dec; 13(12):e20227. PubMed ID: 35004044
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neutrophils in ANCA-associated vasculitis: Mechanisms and implications for management.
    Ge S; Zhu X; Xu Q; Wang J; An C; Hu Y; Yang F; Wang X; Yang Y; Chen S; Jin R; Li H; Peng X; Liu Y; Xu J; Zhu M; Shuai Z
    Front Pharmacol; 2022; 13():957660. PubMed ID: 36210838
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The clinical analysis of 46 cases with antineutrophil cytoplasmic antibody-associated vasculitis].
    Zhang Q; Zhou HQ; Li YH; Guo J; Xu PH; Lu MH; Liu XL; Wang L; Li SG
    Zhonghua Yi Xue Za Zhi; 2016 Jul; 96(27):2146-9. PubMed ID: 27464538
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interleukin-6 in ANCA-associated vasculitis: Rationale for successful treatment with tocilizumab.
    Berti A; Cavalli G; Campochiaro C; Guglielmi B; Baldissera E; Cappio S; Sabbadini MG; Doglioni C; Dagna L
    Semin Arthritis Rheum; 2015 Aug; 45(1):48-54. PubMed ID: 25841802
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neutrophil Extracellular Traps in ANCA-Associated Vasculitis.
    Söderberg D; Segelmark M
    Front Immunol; 2016; 7():256. PubMed ID: 27446086
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Renal involvement in eosinophilic granulomatosis with polyangiitis.
    Reggiani F; L'Imperio V; Calatroni M; Pagni F; Sinico RA
    Front Med (Lausanne); 2023; 10():1244651. PubMed ID: 37790127
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical presentation and outcome prediction of clinical, serological, and histopathological classification schemes in ANCA-associated vasculitis with renal involvement.
    Córdova-Sánchez BM; Mejía-Vilet JM; Morales-Buenrostro LE; Loyola-Rodríguez G; Uribe-Uribe NO; Correa-Rotter R
    Clin Rheumatol; 2016 Jul; 35(7):1805-16. PubMed ID: 26852317
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Myeloperoxidase anti-neutrophil cytoplasmic antibody-associated vasculitis with a unique imaging presentation of organizing pneumonia: A case report.
    Takada K; Miyamoto A; Nakahama H; Moriguchi S; Takahashi Y; Ogawa K; Murase K; Hanada S; Morokawa N; Kurosaki A; Fujii T; Hasegawa E; Takaya H; Takai D
    Respir Med Case Rep; 2020; 31():101294. PubMed ID: 33294358
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Type of ANCA May Be Indispensable in Distinguishing Subphenotypes of Different Clinical Entities in ANCA-Associated Vasculitis.
    Konstantouli AM; Lioulios G; Stai S; Moysidou E; Fylaktou A; Papagianni A; Stangou M
    Life (Basel); 2022 Sep; 12(10):. PubMed ID: 36294902
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical characteristics and outcome of Spanish patients with ANCA-associated vasculitides: Impact of the vasculitis type, ANCA specificity, and treatment on mortality and morbidity.
    Solans-Laqué R; Fraile G; Rodriguez-Carballeira M; Caminal L; Castillo MJ; Martínez-Valle F; Sáez L; Rios JJ; Solanich X; Oristrell J; Pasquau F; Fonseca E; Zamora M; Callejas JL; Frutos B; Abdilla M; Fanlo P; García-Sánchez I; López-Dupla M; Sopeña B; Pérez-Iglesias A; Bosch JA;
    Medicine (Baltimore); 2017 Feb; 96(8):e6083. PubMed ID: 28225490
    [TBL] [Abstract][Full Text] [Related]  

  • 38. ANCA-associated vasculitis in patients with primary Sjögren's syndrome: detailed analysis of 7 new cases and systematic literature review.
    Guellec D; Cornec-Le Gall E; Groh M; Hachulla E; Karras A; Charles P; Dunogué B; Abad S; Alvarez F; Gérard F; Devauchelle-Pensec V; Pers JO; Puéchal X; Guillevin L; Saraux A; Cornec D;
    Autoimmun Rev; 2015 Aug; 14(8):742-50. PubMed ID: 25916811
    [TBL] [Abstract][Full Text] [Related]  

  • 39. ANCA-associated vasculitis in childhood: recent advances.
    Calatroni M; Oliva E; Gianfreda D; Gregorini G; Allinovi M; Ramirez GA; Bozzolo EP; Monti S; Bracaglia C; Marucci G; Bodria M; Sinico RA; Pieruzzi F; Moroni G; Pastore S; Emmi G; Esposito P; Catanoso M; Barbano G; Bonanni A; Vaglio A
    Ital J Pediatr; 2017 May; 43(1):46. PubMed ID: 28476172
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.